Trial Profile
Diagnostic study of 18F-FEMPA in patients with Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2014
Price :
$35
*
At a glance
- Drugs 18F FEMPA (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 20 Nov 2014 New trial record